Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Change in Receivables (2019 - 2021)

Vistagen Therapeutics (VTGN) has disclosed Change in Receivables for 5 consecutive years, with $3400.0 as the latest value for Q4 2021.

  • Quarterly Change in Receivables changed N/A to $3400.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$3400.0 through Sep 2021, changed N/A year-over-year, with the annual reading at $40600.0 for FY2021, 113.53% up from the prior year.
  • Change in Receivables hit $3400.0 in Q4 2021 for Vistagen Therapeutics, up from -$40600.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $40600.0 in Q1 2021 to a low of -$300000.0 in Q2 2019.